“Valneva Makes History: UK Grants Marketing Approval for Groundbreaking Chikungunya Vaccine – IXCHIQ”

Valneva Announces Marketing Authorization for Chikungunya Vaccine in the UK Saint Herblain (France), February 5, 2025 Valneva SE, a specialty vaccine company, has made a groundbreaking announcement today. The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the United Kingdom for the world’s first and only chikungunya vaccine, IXCHIQ®. This single-dose…

Read More

EUR/USD Rebounds as Market Pressures Ease

The Euro Rises Against the Dollar Amid Market Volatility EUR/USD Lurches Higher The EUR/USD pair surged by eight-tenths of one percent on Tuesday, bouncing back from previous losses but failing to break through the 1.0400 level. This movement, known as Fiber in the forex market, ended a six-day losing streak. However, the overall bullish momentum…

Read More

“Equinor Launches First Tranche of 2025 Share Buy-Back Program: A Strategic Move for Investors”

Equinor Launches Share Buy-Back Programme in 2025 Overview Equinor (OSE: EQNR, NYSE: EQNR) has announced the commencement of the first tranche of their share buy-back programme for 2025. Starting on 6 February 2025, the company plans to repurchase up to USD 1.2 billion of its shares. Background This decision was announced at the Capital Market…

Read More